INS and type 1 diabetes mellitus: The case of T1DM is also interesting as research was conducted on the transition of patients from devices that allow for the management of glycemia and insulin delivery in a semiautomated way to a closed-loop insulin delivery system, which is designed to “free” the patient from self-management by automating the process of insulin delivery.